Nurith Aizenman
[Copyright 2024 NPR]
-
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed? -
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter. -
Can we end poverty, provide food for all and otherwise make Earth a better place by 2030? By all accounts, the answer is no. So then what's the point of the Sustainable Development Goals? -
Only one company makes the currently used monkeypox vaccine. Supply is limited in wealthy nations like the U.S. Less well-off nations, like Nigeria, where the outbreak began, have no vaccines at all. -
How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine. -
Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it. -
Two women in Uvalde are spearheading an effort to soothe their community with food. Because Uvalde's resident's lives are so intertwined, everyone knows someone affected by the massacre. -
The U.S. has pulled back funding for global vaccinations. Some countries — like Brazil — don't need the help. Vaccination rates remain low in other countries such as Iraq due to issues of mistrust.
-
That's what Tedros Adhanom Ghebreyesus of the World Health Organization and others ask in the wake of the outpouring of money to help Ukrainian victims of the war amid record levels of global hunger. -
As the world enters the pandemic's 3rd year, some ask whether the 70% vaccination goal set by WHO and the Biden administration could in fact be detrimental. Also: See our map of global progress.
